Eficacia y seguridad de azitromicina en el tratamiento de la infección genital femenina por chlamydia trachomatis

Narciso Reyes, Maria Lourdes E; Casanova Roman, Gerardo; Arredondo García, José Luis.
Ginecol. obstet. Méx ; 61(9): 261-4, sept. 1993. tab
Artigo em Espanhol | LILACS | ID: lil-134837

Documentos relacionados

  1. Azithromycin or Doxycycline for Asymptomatic Rectal <i>Chlamydia trachomatis</i>.
  2. A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.
  3. Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines Initiative.
  4. Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus.
  5. The formation of Fe<sup>3+</sup>-doxycycline complex is pH dependent: implications to doxycycline bioavailability.
  6. Titanium platelet-rich fibrin (T-PRF) as high-capacity doxycycline delivery system.
  7. Challenges in Treating <i>Chlamydia trachomatis</i>, Including Rectal Infections: Is It Time to Go Back to Doxycycline?
  8. An oral caspase inhibitor as monotherapy or with antibiotics eradicates MRSA skin infections in mice.
  9. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
  10. Tetracyclines resistance in Mycoplasma and Ureaplasma urogenital isolates derived from human: a systematic review and meta-analysis.